Page last updated: 2024-10-22

anthralin and Parapsoriasis

anthralin has been researched along with Parapsoriasis in 1 studies

Anthralin: An anthracene derivative that disrupts MITOCHONDRIA function and structure and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS.
anthralin : An anthracene compound derived by the substitution of -OH groups for hydrogen at C-1 and C-8, and with an oxo group at C-9.

Parapsoriasis: The term applied to a group of relatively uncommon inflammatory, maculopapular, scaly eruptions of unknown etiology and resistant to conventional treatment. Eruptions are both psoriatic and lichenoid in appearance, but the diseases are distinct from psoriasis, lichen planus, or other recognized dermatoses. Proposed nomenclature divides parapsoriasis into two distinct subgroups, PITYRIASIS LICHENOIDES and parapsoriasis en plaques (small- and large-plaque parapsoriasis).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Watson, W1
Farber, EM1

Other Studies

1 other study available for anthralin and Parapsoriasis

ArticleYear
Controlling psoriasis.
    Postgraduate medicine, 1977, Volume: 61, Issue:6

    Topics: Adrenal Cortex Hormones; Anthralin; Arthritis; Coal Tar; Diagnosis, Differential; Humans; Methotrexa

1977